chapter
review
immun
respons
viral
infect
regul
effector
arm
respons
matur
cours
infect
beyond
complex
antivir
immun
respons
great
requir
select
topic
discuss
consequ
focu
almost
entir
adapt
antigenspecif
immun
respons
refer
briefli
innat
immun
discuss
adapt
immun
although
cover
antibodi
cell
favor
cell
overal
intent
describ
adapt
immun
respons
focus
quantit
qualit
chang
occur
cours
viral
infect
past
sever
thousand
year
urban
human
societi
permit
viral
infect
wreak
havoc
human
health
led
smallpox
virus
kill
incapacit
hundr
million
peopl
throughout
past
centuri
advent
widespread
antivir
vaccin
dramat
effect
permit
erad
smallpox
viru
approach
extirp
polioviru
also
come
close
consign
diseas
measl
mump
rubella
page
histori
despit
progress
virus
continu
exact
heavi
toll
human
suffer
human
immunodefici
viru
hiv
thought
infect
almost
one
four
african
gregson
et
al
previous
unidentifi
virus
emerg
caus
substanti
harmmost
recent
exemplifi
novel
coronaviru
caus
sever
acut
respiratori
syndrom
sar
kuiken
et
al
old
adversari
influenza
viru
give
sporad
remind
threat
pose
shortridg
et
al
main
bulwark
protect
popul
microbi
onslaught
immun
system
efficaci
antivir
immun
respons
well
establish
major
infect
even
virus
consid
highli
pathogen
resolv
immunocompet
host
ii
requir
intact
immun
system
even
normal
innocu
viru
infect
fatal
immunosuppress
individu
iii
enorm
benefit
antivir
vaccin
reli
adapt
immun
respons
import
vaccin
well
demonstr
current
reemerg
measl
import
human
pathogen
irrat
parent
fear
measl
vaccin
side
effect
led
reduc
vaccin
uptak
countri
potenti
catastroph
consequ
sporad
outbreak
measl
area
unit
state
low
vaccin
uptak
robbin
unit
kingdom
parent
accept
mmr
vaccin
drop
level
may
eventu
permit
measl
viru
becom
endem
jansen
et
al
perhap
strike
low
vaccin
coverag
result
explos
measl
japanan
estim
case
annual
nakayama
et
al
death
number
hundr
thu
address
current
futur
viral
challeng
improv
safeti
efficaci
avail
antivir
vaccin
imper
immun
respons
viral
infect
fulli
understood
immun
respons
classifi
sever
way
consid
classif
logic
antigen
specif
thu
immun
respons
may
term
nonantigenspecif
antigenspecif
name
indic
nonantigenspecif
respons
reli
recognit
specif
antigen
motif
respons
broadbas
includ
phagocyt
natur
killer
cell
type
interferon
barrier
defens
skin
lysozym
gastric
acid
action
exert
earli
cours
combat
infect
requir
form
antigen
instruct
consequ
term
innat
immun
respons
contrast
antigenspecif
immun
system
learn
experi
thu
term
adapt
immun
upon
first
encount
given
antigen
antigenspecif
respons
somewhat
slow
develop
usual
becom
detect
innat
respons
approach
peak
howeverand
contrast
innat
responsesupon
second
exposur
agent
antigenspecif
respons
greatli
improv
quantiti
qualiti
enhanc
antigenspecif
secondari
immun
responsesterm
anamnest
greek
word
recal
origin
memori
cell
specif
antigen
previous
encount
cornerston
antivir
vaccin
innat
adapt
immun
respons
play
key
role
control
viral
infect
becom
increasingli
clear
respons
previous
suppos
separ
instead
inextric
link
howev
goal
chapter
cover
adapt
respons
shall
provid
descript
innat
immun
system
herein
adapt
immun
reli
lymphocyt
two
class
tlymphocyt
deriv
thymu
b
lymphocyt
name
avian
organ
bursa
fabriciu
b
lymphocyt
give
rise
antibodyproduc
plasma
cell
antibodi
act
mainli
diminish
infect
free
viru
wherea
cell
recogn
often
kill
infect
cell
thu
antibodi
lymphocyt
act
complementari
manner
antibodi
neutral
virus
fluid
phase
eg
blood
lymph
interstiti
space
therebi
reduc
number
infect
cell
eas
lymphocyt
workload
lymphocyt
kill
infect
cell
viru
matur
occur
minim
releas
infecti
viru
thu
eas
load
antibodi
follow
page
shall
review
biolog
b
lymphocyt
respons
viru
infect
vaccin
preexist
antibodi
provid
first
line
defens
infect
potenti
serum
transfer
prevent
treatment
infecti
diseas
first
appreci
year
ago
serumor
plasmaderiv
antibodi
prepar
therapeut
resourc
avail
prior
advent
antibiot
antivir
drug
develop
pathogenspecif
vaccin
although
highli
effect
vaccin
play
predomin
role
protect
mani
viral
bacteri
pathogen
recent
year
develop
safer
human
monoclon
antibodi
togeth
better
understand
antimicrobi
role
humor
immun
led
resurg
studi
antibodymedi
protect
diseas
herein
describ
antivir
function
antibodi
molecul
role
humor
immun
varieti
acut
chronic
viral
infect
b
lymphocyt
recogn
microbi
antigen
via
b
cell
receptor
bcr
commonli
term
immunoglobulin
ig
antibodi
ab
cellsurfac
molecul
b
cell
matur
plasma
cell
synthes
secret
form
sever
differ
class
isotyp
ig
see
follow
paragraph
shall
use
abund
class
igg
basi
descript
structur
antibodi
gene
encod
igg
molecul
compris
four
chain
two
heavi
h
two
light
l
h
chain
compos
ntermin
variabl
region
follow
three
constant
domain
almost
ident
within
one
antibodi
class
eg
igg
igm
defin
effector
function
antibodi
class
l
chain
contain
one
variabl
one
constant
region
l
chain
noncoval
pair
one
h
chain
contigu
h
l
variabl
region
togeth
form
one
antigen
recognit
site
therebi
defin
antigen
specif
antibodi
two
ident
hl
chain
pair
noncoval
link
form
canon
yshape
igg
molecul
two
antigen
recognit
site
yshape
structur
common
antibodi
class
section
dna
sequenc
encod
constant
variabl
region
physic
separ
germ
line
undergo
rearrang
form
gene
encod
h
l
chain
furthermor
variabl
region
gener
rearrang
small
genet
segment
variabl
region
heavi
chain
result
rearrang
three
segment
term
v
h
h
j
h
variabl
region
l
chain
form
fusion
v
l
segment
j
l
segment
varieti
v
j
segment
present
genom
combinatori
aspect
antibodi
gene
format
allow
rel
small
number
v
j
segment
gener
larg
number
differ
variabl
region
estim
human
around
l
chain
heavi
h
chain
h
l
chain
associ
randomli
provid
possibl
combin
thu
antigen
specif
hl
pair
addit
process
v
j
rearrang
small
number
nucleotid
ad
lost
junction
divers
increas
number
differ
hl
specif
around
antibodi
divers
increas
process
somat
hypermut
describ
later
antibodi
exert
antimicrobi
effect
varieti
differ
mechan
burton
instanc
viru
neutral
prior
infect
target
cell
occur
antibodi
bind
surfac
viru
steric
hindranc
block
abil
bind
target
altern
antibodi
directli
virucid
may
activ
complement
cascad
review
spear
et
al
lead
disrupt
viral
membran
addit
mechan
direct
antibodymedi
kill
invad
pathogen
mani
type
phagocyt
cell
express
antibodi
fcreceptor
antibodi
bind
receptor
coat
phagocyt
allow
recogn
engulf
destroy
microbi
pathogen
although
antibodi
function
exert
free
viru
particl
case
viru
remain
vulner
antibodymedi
destruct
even
enter
host
cell
viru
protein
present
cell
surfac
recogn
ensu
antivir
antibodi
respons
destruct
infect
target
cell
may
occur
mean
complementdepend
cytotox
destruct
antibodydepend
cellcytotox
mediat
nk
cell
cell
type
express
appropri
fcreceptor
exampl
research
examin
direct
ex
vivo
cytolyt
respons
volunt
immun
vaccinia
could
detect
direct
ex
vivo
tcellmedi
lytic
respons
instead
found
direct
ex
vivo
lytic
activ
requir
nk
cell
vacciniaspecif
antibodi
perrin
et
al
interestingli
antibodi
necessarili
need
destroy
infect
cell
stop
slow
spread
infect
antibodi
shown
block
viru
releas
infect
cell
gerhard
vanderplasschen
et
al
interrupt
celltocel
spread
burioni
et
al
pantaleo
et
al
vanderplasschen
et
al
case
neurotrop
virus
measl
fujinami
oldston
sindbi
viru
levin
et
al
antivir
antibodi
may
block
viral
replic
without
directli
result
destruct
infect
cell
togeth
studi
demonstr
humor
immun
result
multitud
independ
interrel
mechan
antivir
activ
antibodi
produc
five
differ
class
igg
igm
iga
igd
ige
antibodi
molecul
differ
molecular
composit
well
biolog
function
padlan
igg
abund
class
immunoglobulin
serum
mean
adult
serum
level
mgml
human
organ
four
subclass
respect
constitut
approxim
total
serum
igg
main
effector
function
share
four
igg
subclass
neutral
although
human
also
effect
activ
complement
system
especi
effect
opson
process
pathogen
becom
coat
antibodi
multipl
expos
igg
constant
domain
facilit
intern
phagocyt
express
fc
receptor
opson
gener
import
counter
bacteri
rather
viral
infect
igm
structur
similar
igg
molecul
h
chain
carri
fourth
constant
region
first
immunoglobulin
express
surfac
develop
b
cell
cell
matur
antibodi
secret
plasma
form
starshap
multimer
array
five
antibodi
plasma
igm
molecul
therefor
contain
antigen
recognit
site
multipl
antigenbind
site
would
seem
make
igm
wellsuit
neutral
perhap
surpris
main
biolog
role
appear
complement
activ
iga
similar
appear
igg
form
dimer
capac
activ
transfer
across
epitheli
surfac
allow
entri
lumin
space
result
dimer
iga
key
factor
provid
barrier
mucos
immun
ige
structur
similar
singl
igm
molecul
four
constant
region
h
chain
form
multim
serum
level
order
magnitud
lower
class
instead
found
surfac
mast
cell
play
role
allergi
perhap
immun
parasit
igd
superfici
similar
igg
function
remain
unknown
although
substitut
igm
genet
defect
prevent
synthesi
antibodi
class
lutz
et
al
biolog
featur
three
class
import
control
viru
infectionigm
igg
igaar
summar
tabl
sever
possibl
outcom
viru
infect
viru
famili
caus
acut
ie
shortliv
infect
wherea
other
persist
host
month
year
therefor
import
understand
role
play
antibodi
prevent
infect
diseas
progress
wide
dispar
circumst
one
school
thought
antibodi
play
key
role
control
acut
infect
persist
infect
kagi
hengartn
author
note
acut
infect
infect
cell
rapidli
destroy
viru
therefor
cellular
immun
exert
effect
act
infect
cell
may
minim
import
circumst
host
must
reli
antivir
antibodi
contrast
cellular
immun
may
import
antibodi
persist
infect
host
goal
erad
viru
hide
insid
cell
propos
fit
data
prophylact
therapeut
efficaci
antibodi
number
human
virus
summar
tabl
ii
support
hypothesi
mani
instanc
lytic
viral
infect
notabl
poxvirus
flavivirus
highli
suscept
antibodydepend
immun
howev
sever
except
preexist
antibodi
respons
typic
nonlyt
persist
viru
appear
afford
partial
case
complet
protect
infect
exampl
arenavirus
persist
lifetim
host
well
establish
administr
convalesc
serum
plasma
result
signific
level
protect
lethal
junin
viru
infect
enria
barrera
oro
although
result
protect
lassa
fever
viru
anoth
member
arenaviru
famili
mix
clayton
mccormick
prototyp
arenaviru
lcmv
establish
lifelong
persist
mice
immun
agent
mediat
larg
cell
consist
hypothesi
monoclon
lcmvspecif
antibodi
howev
amelior
diseas
wright
buchmeier
vaccin
appear
induc
antibodi
absenc
protect
level
cell
also
could
confer
protect
di
simon
buchmeier
indic
hypothesi
may
oversimplif
result
outlin
tabl
ii
illustr
import
point
antibodi
gener
effect
prophylact
therapeut
preexist
antibodi
acquir
immun
passiv
transfer
often
prevent
least
amelior
diseas
caus
subsequ
viru
infect
antibodi
less
effect
administ
sever
diseas
symptom
appear
may
due
overwhelm
level
viru
adequ
control
finit
amount
transfer
antibodi
convers
may
littl
viru
remain
time
symptom
sever
mani
symptom
viral
diseas
reflect
immunopatholog
occur
viru
clearanc
slifka
whitton
see
section
vi
nevertheless
antibodymedi
therapi
begin
gain
wider
accept
especi
human
monoclon
antibodi
easili
obtain
use
place
convalesc
sera
exampl
palivizumab
first
human
monoclon
antibodi
licens
prevent
respiratori
syncyti
viru
rsv
infect
sinc
introduct
signific
impact
number
durat
rsvassoci
hospit
suscept
infant
popul
romero
monoclon
antibodi
formul
also
show
promis
anim
model
combin
monoclon
antibodi
shown
effect
postexposur
prophylaxi
rabi
viru
prosniak
et
al
vagin
appli
monoclon
antibodi
direct
molecul
protect
mucos
viru
transmiss
veazey
et
al
monoclon
antibodi
therapi
least
two
major
advantag
convalesc
serum
includ
low
lottolot
variat
neutral
titer
give
guarante
standard
therapeut
efficaci
ii
significantli
decreas
risk
contamin
human
virus
clinic
relev
pathogen
common
risk
factor
encount
administ
convalesc
serum
plasma
addit
produc
antibodi
directli
combat
microbi
infect
b
cellsmost
promin
memori
b
cellsalso
help
regul
immun
respons
act
antigenpres
cell
memori
b
cell
detect
lymphoid
organ
bloodstream
within
week
acut
viral
infect
maintain
steadyst
level
thereaft
cell
secret
antibodi
instead
maintain
cellsurfac
express
immunoglobulin
receptor
recogn
specif
antigen
bound
antigen
intern
process
viral
epitop
present
cell
surfac
major
histocompat
complex
mhc
class
ii
molecul
complex
surfac
memori
b
cell
extrem
effect
trigger
antigenspecif
cell
respons
lanzavecchia
import
describ
highli
activ
memori
b
cell
also
prolifer
differenti
antibodysecret
plasma
cell
main
cell
type
involv
maintain
antibodi
level
vaccin
infect
appear
clear
divis
labor
relat
cell
type
memori
b
cell
mainli
involv
antigen
process
present
mount
anamnest
immun
respons
wherea
plasma
cell
unlik
involv
antigen
uptak
present
larg
defici
surfac
immunoglobulin
show
littl
mhc
class
ii
express
abney
et
al
halper
et
al
slifka
et
al
plasma
cell
instead
devot
energi
product
secret
antibodi
mani
virus
mani
vaccin
live
inert
induc
antibodi
respons
remain
detect
year
antigen
exposur
sinc
halflif
antibodi
molecul
measur
week
longev
respons
must
explain
ongo
antibodi
synthesi
gener
agreement
longterm
antibodi
level
maintain
combin
effort
two
larg
distinct
cell
type
memori
b
cell
plasma
cell
substanti
controversi
regard
role
play
plasma
cell
secret
molecul
antibodi
per
second
helmreich
et
al
hibi
dosch
typic
measur
elispot
techniqu
detect
spontan
antibodi
product
individu
cell
plasma
cell
accumul
spleen
drain
lymph
node
earli
stage
acut
viral
infect
infect
resolv
local
immun
respons
subsid
major
virusspecif
plasma
cell
typic
found
bone
marrow
compart
bachmann
et
al
hyland
et
al
slifka
et
al
youngman
et
al
mani
year
believ
plasma
cell
shortliv
halflif
less
day
thu
requir
continu
replenish
prolifer
memori
b
cell
longliv
antibodi
respons
maintain
slifka
ahm
note
memori
b
cell
undoubtedli
differenti
plasma
cell
thought
must
high
frequenc
replac
shortliv
plasma
cell
howev
notion
recent
challeng
studi
demonstr
individu
plasma
cell
surviv
month
year
absenc
prolifer
manz
et
al
without
reconstitut
resid
memori
b
cell
mice
virusspecif
plasma
cell
could
observ
day
memori
b
cell
deplet
indic
least
subpopul
plasma
cell
could
surviv
life
host
life
span
plasma
cell
human
current
unknown
interest
learn
whether
plasma
cell
larger
longliv
mammal
maxim
life
span
year
found
mice
whether
life
span
extend
commensur
host
longev
matur
cours
infect
b
cell
respons
matur
least
three
way
cours
viral
infect
first
b
cell
produc
secret
ig
molecul
antibodi
naiv
b
cell
express
igm
restrict
cell
surfac
follow
appropri
encount
cognat
antigen
cell
activ
begin
divid
produc
secret
multimer
form
igm
facilit
activ
complement
cascad
second
b
cell
undergo
class
switch
allud
previous
process
variabl
region
henc
antigen
specif
antibodi
remain
unchang
h
chain
constant
domain
rearrang
exampl
igm
constant
domain
may
replac
igg
constant
domain
igmsecret
b
cell
instead
secret
igg
ident
antigen
specif
differ
structur
dival
instead
decaval
new
effector
function
eg
enter
interstiti
space
better
neutral
activ
see
tabl
third
process
expans
result
antigen
contact
multipl
mutat
introduc
variabl
region
antigenspecif
b
cell
process
term
somat
hypermut
somat
hypermut
least
two
consequ
one
consequ
mani
chang
may
reduc
abolish
recognit
trigger
antigen
result
b
cell
antibodi
may
recogn
differ
antigen
moieti
thu
process
increas
divers
antibodi
respons
high
specif
anoth
consequ
mutat
increas
antibodi
affin
origin
antigen
b
cell
express
improv
ig
molecul
preferenti
expand
continu
antigen
contact
result
long
antigen
present
drive
respons
overal
affin
antigenspecif
antibodi
popul
increas
antibodi
reach
extrem
high
affin
rang
k
antibodi
begin
extend
high
highaffin
antibodi
specif
cognat
antigen
diminish
risk
side
effect
stronger
bind
enhanc
effector
function
eg
neutral
complement
fixat
etc
strong
bind
individu
antibodi
antigen
may
effect
irrevers
therefor
antibodi
consid
dispos
effector
molecul
describ
next
featur
distinguish
matur
antibodi
respons
chang
cell
respons
take
place
infect
contrast
antibodi
gener
recogn
antigen
moieti
intact
molecul
lymphocyt
recogn
short
amino
acid
fragment
epitop
foreign
protein
present
cell
surfac
host
glycoprotein
encod
mhc
antigen
recognit
cell
reli
cell
receptor
tcr
cell
surfac
molecul
present
multipl
ident
copi
structur
reminisc
one
arm
antibodi
molecul
tcr
heterodim
chain
compris
one
constant
region
common
cell
one
variabl
region
vari
among
differ
cell
two
categori
tcr
function
cell
bear
heterodim
remain
larg
unknown
discuss
review
great
major
cell
respond
viral
infect
express
tcr
heterodim
popul
intens
studi
past
decad
pair
variabl
region
tcr
determin
antigen
specif
therefor
specif
cell
cell
subdivid
two
major
class
distinguish
express
cell
surfac
protein
term
two
major
type
mhc
molecul
class
class
ii
gener
cell
recogn
peptid
epitop
present
cell
surfac
mhc
class
cell
recogn
peptid
present
mhc
class
ii
recognit
process
broadli
speak
tcr
recogn
specif
combin
peptid
epitop
mhc
molecul
thu
confer
antigen
specif
upon
cell
molecul
interact
directli
conserv
area
respect
mhc
molecul
konig
et
al
salter
et
al
increas
avid
interact
help
assembl
signal
transduct
apparatu
least
two
key
differ
mhc
class
class
ii
molecul
defin
biolog
role
cell
summar
tabl
iii
first
molecul
differ
distribut
class
molecul
almost
ubiquit
wherea
class
ii
molecul
express
rel
limit
number
cell
special
antigen
present
cell
apc
import
induct
immun
respons
second
molecul
differ
sourc
viral
peptid
present
mhc
class
molecul
present
epitop
protein
made
within
cell
thu
ensur
gener
cell
recogn
cell
activ
infect
viru
contrast
mhc
class
ii
molecul
present
peptid
come
protein
taken
extracellular
milieu
thu
special
apc
recogn
cell
even
activ
infect
differ
mhc
distribut
function
profound
implic
biolog
activ
lymphocyt
cell
principl
recogn
exert
effect
almost
somat
cell
unfortun
enough
becom
infect
thu
cell
effect
front
line
combat
viru
infect
contrast
cell
unabl
recogn
major
infect
cell
therefor
less
plausibl
candid
direct
control
infect
although
may
direct
effect
section
howev
interact
special
apc
ensur
cell
play
import
role
marshal
immun
respons
might
expect
differ
role
counter
viru
infect
two
cell
type
differ
somewhat
way
respond
infect
therefor
shall
consid
separ
begin
betterunderstood
cell
respons
case
shall
consid
cours
infect
cell
vari
quantiti
qualiti
virusspecif
cell
develop
naiv
cell
carri
appropri
tcr
encount
special
apc
present
appropri
peptid
via
mhc
class
molecul
eleg
work
shown
mani
case
apc
must
first
activ
pathway
provid
appropri
stimul
naiv
cell
bennett
et
al
ridg
et
al
schoenberg
et
al
kinet
antivir
cell
respons
kinet
antivir
cell
respons
extens
studi
number
anim
model
system
recent
human
care
quantit
provid
rel
detail
pictur
number
virusspecif
andor
epitopespecif
cell
present
phase
infect
lymphocyt
choriomening
viru
lcmv
infect
mice
wide
use
studi
mani
aspect
antivir
immun
quantit
overview
lcmvspecif
cell
respons
present
fig
respons
tradit
consid
three
phase
expans
contract
memori
although
shown
figur
entir
separ
tempor
overlap
phase
expans
phase
begin
naiv
antigenspecif
cell
encount
cognat
antigen
result
trigger
program
lead
cell
divis
differenti
studi
mice
indic
may
approxim
naiv
cell
specif
given
antigen
sinc
mous
cell
total
frequenc
naiv
cell
given
antigen
specif
would
blattman
et
al
inde
mous
contain
cell
approxim
differ
specif
far
number
antibodi
specif
avail
anim
may
implic
either
number
epitop
recogn
fidel
tcrantigen
recognit
trigger
naiv
cell
requir
receiv
least
two
signal
contact
cognat
epitop
deliv
via
tcr
ii
costimulatori
signal
come
varieti
receptorligand
interact
widespread
express
mhc
class
molecul
ensur
somat
cell
present
viral
antigen
cell
cell
typesin
particular
activ
dendrit
cell
memori
b
cellsexpress
appropri
costimulatori
molecul
consequ
cellsloc
lymphoid
tissu
lymph
nodescan
trigger
naiv
cell
enter
activ
pathway
interact
naiv
cell
activ
apc
express
cognat
antigen
may
rather
brief
recent
studi
sever
laboratori
indic
hour
antigen
exposur
requir
caus
cell
progeni
proceed
expans
contract
memori
phase
express
appropri
effector
function
kaech
ahm
mercado
et
al
van
stipdonk
et
al
follow
antigen
trigger
cell
divid
continu
rather
rapidli
cell
respons
shown
fig
intend
demonstr
quantit
chang
may
take
place
singl
popul
naiv
cell
specif
epitop
first
day
viral
infect
naiv
cell
may
undergo
approxim
round
divis
permit
singl
cell
gener
progeni
blattman
et
al
graph
fig
assum
naiv
cell
receiv
appropri
antigen
signal
may
occur
vivo
exampl
circumst
increas
antigen
epitop
express
increas
overal
epitopespecif
cell
respons
wherri
et
al
fig
quantit
overview
cell
respons
viral
epitop
graph
repres
chang
occur
respons
lcmv
infect
popul
naiv
cell
ident
viral
epitop
specif
prior
infect
size
pool
ident
precursor
cell
assum
cell
accord
data
blattman
et
al
expans
contract
memori
phase
indic
shade
note
section
iva
transit
post
infect
pi
phase
abrupt
like
substanti
tempor
overlap
success
phase
graph
consid
repres
graph
kinet
cell
respons
differ
depend
natur
infect
eg
viru
acut
vs
persist
infect
consist
possibl
lower
express
may
recruit
proport
epitopespecif
naiv
cell
respond
popul
also
possibl
naiv
cell
activ
level
epitop
express
higher
level
led
increas
prolifer
eg
rapid
prolong
cell
divis
regardless
mechan
like
quantiti
antigen
avail
earli
phase
infect
play
key
role
determin
intens
cell
respons
durat
antigen
avail
mark
effect
effect
persist
antigen
unclear
suggest
persist
antigen
may
caus
relat
cell
undergo
round
cell
divis
other
note
durat
antigen
exposur
minim
effect
cell
respons
summari
naiv
cell
preprogram
brief
antigen
contact
expand
express
effector
function
contract
enter
memori
phase
relianc
easili
trigger
program
may
advantag
disadvantag
virus
develop
mani
strategi
evad
immun
system
includ
rapid
downregul
apc
function
cell
requir
prolong
repeat
contact
antigencharg
apc
would
signific
risk
virus
could
undermin
develop
cell
respons
limit
apc
function
brief
antigen
contact
need
initi
program
host
better
chanc
abl
mount
meaning
respons
addit
advantag
program
may
permit
activ
cell
quickli
exit
lymphoid
tissu
initi
trigger
occur
presum
continu
rapid
divis
peripher
site
even
absenc
ongo
antigen
contact
way
antivir
function
expand
cell
popul
rapidli
deploy
would
cell
remain
lymphoid
tissu
receiv
repeat
antigen
signal
possibl
disadvantag
program
cell
may
continu
expand
long
viru
antigen
erad
potenti
harm
autoaggress
cell
may
play
role
virusinduc
autoimmun
diseas
upon
activ
cell
upregul
express
sever
activ
marker
receptor
also
downregul
molecul
includ
lselectin
ccchemokin
receptor
understand
protein
function
incomplet
sever
protein
appear
play
import
part
regul
anatom
distribut
cell
known
mani
year
lymphocyt
recircul
random
cell
retain
lymph
node
other
prefer
peripher
tissu
cahil
et
al
naiv
cell
appear
remain
lymphoid
tissu
express
cell
surfac
high
level
protein
gallatin
et
al
mediat
adhes
lymph
node
venul
baekkevold
et
al
cell
activ
result
rapid
downregul
protein
along
factor
allow
cell
exit
node
releas
node
cell
patrol
peripher
tissu
settl
preferenti
tissu
express
particular
ligand
andor
chemokin
interact
protein
cell
membran
exampl
increas
evid
cell
home
specif
organ
although
remain
uncertain
whether
behavior
imprint
individu
cell
apc
prime
whether
behavior
result
posit
select
activ
cell
carri
appropri
cellsurfac
molecul
event
appear
viral
infect
inflammatori
process
cell
traffick
tightli
control
review
wening
et
al
past
decad
expans
memori
phase
cell
respons
exhaust
studi
interven
contract
death
phase
receiv
much
less
attent
although
situat
chang
understand
contract
phase
best
elementari
result
terminolog
confus
literatur
doubt
resolv
clear
pictur
contract
phase
emerg
come
year
alreadi
note
cell
die
contract
phase
rel
brief
complet
approxim
day
postinfect
kaech
et
al
sprent
surh
although
expans
contract
phase
usual
consid
tempor
distinct
probabl
oversimplif
cell
death
begin
even
cell
number
continu
rise
thu
approxim
day
postinfect
expans
contract
phase
overlap
conceptu
one
propos
least
four
gener
mechan
might
precipit
cell
contract
mechan
necessarili
mutual
exclus
first
activ
cell
may
destin
die
regardless
milieu
find
exampl
propos
naiv
cell
first
encount
cognat
antigen
program
may
trigger
lead
death
progeni
cell
certain
number
divis
intrigu
hypothesi
experiment
evid
consist
earli
program
event
howev
earli
program
take
place
unlik
sole
regul
contract
fate
activ
cell
alter
environ
environment
factor
contribut
remain
three
mechan
second
cell
number
appear
declin
parallel
viral
clearanc
perhap
cell
die
longer
find
cognat
antigen
origin
popular
idea
fallen
favor
third
cell
may
reach
stage
antigen
contact
becom
lethal
rather
stimulatori
activationinduc
cell
death
aicd
fourth
infect
resolv
gener
reduct
proinflammatori
cytokin
statu
activ
cell
could
die
cytokin
withdraw
activ
cell
autonom
death
acad
addit
identifi
factor
precipit
cell
death
import
also
ask
relat
question
molecular
mechan
cell
die
kill
commit
suicid
latter
true
cell
intrins
suicid
act
upon
instruct
studi
suggest
reduct
cell
number
reli
larg
program
cell
death
pcd
process
cell
suicid
central
mani
aspect
cell
regul
tissu
develop
pcd
cell
dismantl
order
manner
contrast
necrosi
process
passiv
cellular
disintegr
pcd
import
variou
aspect
immun
regul
play
crucial
role
thymic
cell
select
kill
virusinfect
cell
cell
relev
chapter
regul
virusspecif
cell
number
follow
infect
mani
paper
cell
contract
state
death
occur
apoptosi
term
pcd
apoptosi
often
use
interchang
howev
two
synonym
sever
cell
type
includ
cell
pcd
also
mediat
trigger
nonapoptot
pathway
studi
suggest
cell
contract
may
larg
nonapoptot
holler
et
al
three
type
pcd
propos
review
jaattela
tschopp
categor
depend
morpholog
die
cell
part
play
caspas
aspartatespecif
cystein
proteas
activ
effector
phase
cell
suicid
cohen
thornberri
lazebnik
classic
apoptosi
chromatin
die
cell
condens
nuclear
margin
caspasedepend
apoptosislik
pcd
also
show
chromatin
condens
may
caspaseindepend
necrosislik
pcd
chromatin
condens
absent
distinguish
regular
necrosi
former
driven
activ
cellular
process
deneck
et
al
vercammen
et
al
shall
discuss
two
main
mechan
thought
respons
pcd
virusspecif
cell
activationinduc
cell
death
aicd
also
call
antigendriven
apoptosi
ii
activ
cell
autonom
death
acad
also
call
growth
factor
deprivationinduc
apoptosi
hildeman
et
al
janssen
et
al
lenardo
et
al
welsh
mcnalli
aicd
activ
cell
express
fasl
molecul
permit
induc
apoptosi
virusinfect
cell
express
death
receptor
fa
fasfasl
interact
initi
caspas
cascad
begin
cleavag
culmin
apoptot
cell
death
review
budd
role
fa
pathway
cell
homeostasi
vivo
strongli
support
observ
mice
lack
fa
lpr
mice
fasl
gld
mice
develop
uncontrol
lymphoprolifer
nagata
suda
howev
inhibit
caspas
pathway
use
either
drug
hildeman
et
al
holler
et
al
genet
manipul
smith
et
al
usual
result
lymphoprolifer
suggest
exist
altern
caspaseindepend
pathway
may
mediat
cell
death
evid
fa
pathway
andor
caspas
cascad
may
play
role
aicd
immun
respons
viru
infect
fa
pathway
thought
central
aicd
antigendriven
overstimul
cell
receptor
induc
fa
express
render
cell
suscept
fasldriven
apoptosi
brunner
et
al
sinc
aicd
antigendriven
thought
play
part
rel
earli
infect
antigen
load
high
furthermor
cell
render
sensit
fastrigg
apoptosi
activ
divid
level
high
refa
et
al
precis
condit
present
later
part
expans
phase
thu
aicd
may
drive
much
cell
death
occur
toward
end
expans
phase
furthermor
aicd
thought
crucial
downregul
antivir
cell
respons
persist
viru
infect
ie
antigen
remain
organ
extend
period
time
zhou
et
al
howev
fact
vitro
induct
aicd
often
requir
repetit
stimul
tcr
led
doubt
contribut
contract
phase
antivir
immun
respons
vivo
hildeman
et
al
togeth
observ
caspaseindepend
death
pathway
led
search
altern
mechan
cell
death
b
acad
acad
thought
respons
bulk
virusspecif
cell
death
occur
viru
erad
ie
later
contract
phase
unlik
aicd
acad
depend
ligat
death
receptor
ie
fasindepend
instead
control
molecular
regul
within
cell
protein
famili
play
key
role
strasser
et
al
van
parij
et
al
famili
compris
least
three
subgroup
protein
array
oppos
faction
first
subgroup
contain
antiapoptot
protein
bclx
l
second
popul
proapoptot
protein
bax
bak
member
third
subgroup
term
protein
favor
apoptosi
inhibit
antiapoptot
rel
enhanc
activ
proapoptot
molecul
one
protein
bim
propos
key
molecular
regul
acad
hildeman
et
al
b
acad
inhibit
express
high
level
select
induc
antiapoptot
member
famili
therebi
prevent
acad
akbar
et
al
furthermor
elev
level
protein
report
memori
cell
grayson
et
al
protein
famili
control
mitochondri
outer
membran
permeabl
proapoptot
famili
member
act
disregul
membran
potenti
vital
organel
lethal
effect
appear
final
common
pathway
employ
variou
induc
caspaseindepend
cell
death
one
consequ
disregul
intracellular
releas
cytochrom
c
turn
activ
trigger
caspas
cascad
thu
caspas
activ
occur
aicd
acad
signific
differ
greatli
two
pathway
aicd
caspas
activ
requir
cell
death
contrast
caspas
activ
secondari
featur
acad
requir
dna
fragment
characterist
apoptosi
cell
death
occur
even
absenc
caspas
ferraropeyret
et
al
summari
least
two
independ
partial
overlap
pathway
may
induc
cell
death
likelihood
one
pathway
activ
one
cell
depend
varieti
factor
may
includ
histori
antigen
contact
number
cell
divis
extracellular
microenviron
peak
infect
rapid
cell
divis
high
level
tend
favor
aicd
inflammatori
milieu
dissip
declin
caus
balanc
power
within
war
faction
famili
shift
lead
chang
mitochondri
membran
potenti
caspaseindepend
cell
death
acad
recent
studi
deliv
vivo
variou
time
cours
antivir
immun
respons
confirm
time
administr
critic
reduc
cell
number
administ
rel
soon
infect
expans
phase
consist
induc
aicd
increas
cell
surviv
administ
contract
phase
consist
prevent
acad
blattman
et
al
memori
cell
play
critic
role
protect
mani
viral
infect
ampl
evid
vaccin
induc
memori
cell
confer
good
protect
subsequ
viral
challeng
del
val
et
al
klavinski
et
al
whitton
et
al
induct
virusspecif
memori
cell
therefor
central
goal
antivir
vaccin
design
number
cell
enter
memori
phase
relat
extent
primari
respons
hou
et
al
marshal
et
al
ontogeni
memori
cell
remain
controversi
studi
suggest
aris
directli
effector
cell
escap
contract
phase
jacob
baltimor
opferman
et
al
passag
memori
phase
may
stochast
process
data
indic
memori
cell
may
repres
separ
lineag
gener
without
express
effector
function
lauvau
et
al
manjunath
et
al
regardless
precis
cell
gener
clear
immunocompet
anim
rest
level
memori
cell
remain
rel
stabl
prolong
period
month
year
infect
vaccin
establish
stabl
cell
memori
popul
requir
cell
mice
lack
cell
primari
cell
respons
ie
expans
phase
rel
normal
number
memori
cell
extent
antivir
protect
decreas
pass
month
von
herrath
et
al
activ
cell
stabil
cell
memori
may
exert
earli
perhap
naiv
cell
program
janssen
et
al
shedlock
shen
sun
bevan
normal
mice
mainten
stabl
level
memori
cell
requir
cell
continu
divid
homeostat
manner
homeostat
divis
regul
cytokin
particular
becker
et
al
schlun
et
al
schlun
et
al
tan
et
al
occur
absenc
cognat
antigen
lau
et
al
muralikrishna
et
al
suggest
sallusto
et
al
may
two
type
memori
cell
term
effector
memori
cell
cytolyt
produc
cytokin
immedi
upon
antigen
encount
central
memori
effectorless
cell
express
ifnor
perforin
immedi
upon
antigen
contact
evalu
express
suggest
cell
central
memori
cell
effector
memori
propos
centralmemori
hypothesi
three
distinguish
tenet
effector
memori
cell
constitut
lytic
cytokin
compet
ii
central
memori
cell
express
neither
cytokin
perforin
upon
antigen
contact
iii
effector
central
memori
popul
distinguish
basi
express
emerg
data
challeng
tenet
hypothesi
first
sever
lab
shown
long
viru
clearanc
virusspecif
memori
cell
quickli
produc
ifnin
respons
antigen
contact
nonlyt
thu
would
exclud
sallustolanzavecchia
definit
effector
memori
cell
second
laboratori
found
almost
virusspecif
memori
cell
identifi
use
tetram
also
cytokin
compet
cell
data
shown
suggest
virusspecif
effectorless
ie
central
memori
cell
exist
minor
compon
respons
similar
find
report
model
infect
masopust
et
al
third
regard
express
pircher
colleagu
unsoeld
et
al
use
new
reagent
detect
mous
lcmv
tcr
transgen
mice
found
day
lcmv
infect
virusspecif
tcr
transgen
cell
lytic
cytokin
compet
show
clear
pattern
level
express
unsoeld
et
al
determin
relationship
express
effector
function
normal
tcr
transgen
cell
infect
mice
lcmv
sever
month
later
effector
function
virusspecif
memori
cell
evalu
directli
ex
vivo
intracellular
cytokin
stain
icc
use
domin
np
peptid
stimul
cell
stain
detect
includ
compar
purpos
addit
determin
effect
antigen
reexposur
longterm
lcmvimmun
mice
reinfect
lcmv
sacrif
day
later
splenocyt
analyz
alreadi
describ
repres
result
shown
fig
cell
shown
cell
axe
repres
fig
fig
prior
secondari
infect
left
column
fig
peptiderespons
ie
memori
cell
spleen
almost
identif
cell
respond
immedi
antigen
contact
consist
centraleffector
memori
hypothesi
four
day
viru
infect
right
column
fig
cytokin
compet
cell
expand
still
statu
markedli
chang
major
respond
cell
thu
data
show
normal
memori
cell
express
correl
absenc
immedi
effector
function
rather
suggest
may
correl
infect
statu
express
decreas
markedli
day
follow
secondari
viru
infect
thought
mediat
attach
endotheli
cell
gunn
et
al
alter
distribut
cell
within
spleen
potsch
et
al
presum
like
downregul
infect
permit
effici
extravas
effector
cell
similar
find
recent
report
other
ravkov
et
al
furthermor
vivo
analys
shown
propos
class
memori
cell
confer
protect
immun
might
better
consid
part
continuum
effector
memori
cell
serv
origin
central
memori
cell
distinguish
anatom
locat
effector
function
summari
although
doubt
memori
cell
may
somewhat
heterogen
function
distribut
littl
support
origin
classif
two
discret
popul
base
marker
express
effector
activ
great
major
publish
work
memori
cell
focus
tissu
cell
abund
usual
spleen
lymph
node
inform
deriv
interest
relev
repres
incomplet
snapshot
antivir
cell
respons
vivo
mani
biolog
effect
must
exert
nonlymphoid
tissu
although
known
mani
year
memori
cell
found
nonlymphoid
tissu
mackay
et
al
sprent
detail
analysi
new
area
research
emerg
data
rather
inconclus
one
studi
show
memori
cell
lung
liver
immedi
cytolyt
masopust
et
al
other
investig
effector
function
memori
cell
lung
parenchyma
airway
found
virusspecif
cell
immedi
cytolyt
hogan
et
al
ostler
et
al
furthermor
even
exhaust
studi
organ
spleen
controversi
remain
selin
welsh
show
small
proport
lcmvspecif
memori
cell
spleen
cytolyt
oehen
brduschariem
extend
observ
lcmv
transgen
tcr
model
demonstr
transgen
lcmvspecif
memori
cell
spleen
cytolyt
shortterm
h
assay
howev
lefrancoi
laboratori
show
contrast
oehen
find
memori
cell
spleen
cytolyt
masopust
et
al
observ
suggest
soon
viru
clear
lytic
activ
rapidli
lost
great
major
lcmvspecif
cell
spleen
rodriguez
et
al
regul
express
cell
effector
function
peripher
tissu
focu
much
studi
come
year
quantiti
cell
resid
site
known
number
virusspecif
memori
cell
peripher
tissu
lung
tissu
remain
rel
stabl
mani
month
remain
uncertain
whether
outcom
achiev
homeostat
divis
lungresid
cell
whether
popul
continu
replenish
immigr
new
memori
cell
lymphoid
tissu
avail
data
favor
second
mechan
eli
et
al
hogan
et
al
virusspecif
lymphocyt
control
microbi
infect
two
gener
way
secret
cytokin
ifnand
tnf
lyse
infect
cell
long
assum
control
viral
infect
cytolyt
function
cell
far
outweigh
contribut
made
releas
cytokin
least
two
mechan
cell
caus
lysi
infect
target
cell
first
insert
poreform
protein
perforin
target
cell
membran
thu
facilit
entri
toxic
molecul
granzym
second
trigger
death
pathway
exemplifi
fasfasl
pathway
pathway
interact
fa
molecul
target
cell
ligand
fasl
cell
result
apoptot
death
infect
cell
mani
probabl
cell
develop
cytolyt
capabl
within
hour
antigen
contact
epitopespecif
cell
differ
cytolyt
capac
virusspecif
cell
rapidli
lose
lytic
activ
viru
clearanc
although
remain
cytokin
competentthat
capabl
produc
cytokin
immedi
upon
antigen
contact
rodriguez
et
al
role
fasfasl
pathway
direct
antivir
defens
unclear
fasfasl
interact
implic
regul
viru
infect
hepatocyt
kafrouni
et
al
neuron
medana
et
al
absenc
perforin
pathway
appear
incap
control
lcmv
infect
walsh
et
al
doubt
perforin
import
clearanc
sever
viru
infect
lcmv
kagi
et
al
walsh
et
al
cytolyt
activ
long
consid
crown
jewel
cell
armamentarium
case
dispens
perforin
play
littl
role
control
infect
caus
vaccinia
semliki
forest
viru
vesicular
stomat
viru
kagi
et
al
rotavirus
franco
et
al
coxsacki
virus
gebhard
et
al
furthermor
exposur
cytokin
directli
reduc
viral
replic
cytokin
alon
abl
cure
infect
cell
inactiv
viral
replic
absenc
cell
death
estcourt
et
al
guidotti
chisari
levi
et
al
walker
et
al
thu
cytokin
cytotox
contribut
antivir
activ
cell
past
decad
major
analys
cell
respons
infect
quantit
rather
qualit
howev
indic
central
memoryeffector
memori
controversi
focu
begin
chang
alreadi
describ
antibodi
respons
matur
cours
infect
upon
reexposur
cognat
antigen
reason
propos
host
might
benefit
virusspecif
cell
also
improv
time
laboratori
investig
possibl
shown
chang
antigen
respons
inde
take
place
identifi
three
distinct
chang
least
two
may
enhanc
abil
cell
control
viru
infect
chang
occur
differ
time
cours
infect
first
complet
day
postinfect
second
complet
day
third
complet
cell
enter
memori
phase
chronolog
reflect
order
present
follow
subsect
one
way
cell
could
enhanc
biolog
efficaci
would
optim
sensit
antigen
contact
could
principl
achiev
increas
affin
tcr
relev
epitopemhc
complex
other
report
day
postinfect
memori
phase
cell
popul
carri
tcr
higher
affin
select
expand
busch
pamer
savag
et
al
howev
lead
small
twofold
fourfold
increas
antigenrespons
cell
popul
sever
reason
appear
tcr
affin
contribut
noth
matur
cell
respons
importantli
contrast
antibodi
whose
affin
cognat
antigen
rang
affin
tcr
peptidemhc
low
vivo
rang
eisen
et
al
valitutti
lanzavecchia
low
affin
unlik
result
structur
constraint
vitro
mutagenesi
tcr
gener
receptor
high
affin
cognat
antigen
holler
et
al
thu
low
affin
tcr
vivo
appear
result
select
pressur
favor
cell
bear
lowaffin
receptor
andor
oppos
cell
express
highaffin
molecul
consist
idea
highaffin
tcr
evolutionarili
desir
receptor
appear
incap
somat
hypermut
sequenc
tcr
naiv
cell
remain
unalt
follow
activ
expans
sever
propos
advanc
explain
vivo
affin
ceil
tcrmhc
interact
highaffin
tcr
may
delet
thymic
select
ii
cell
bear
highaffin
tcr
escap
thymic
delet
may
becom
dysfunct
activ
elimin
prolong
tcr
contact
cognat
antigen
host
peripheri
valitutti
lanzavecchia
iii
cell
carri
tcr
affin
approxim
trigger
low
level
cognat
antigen
host
need
produc
cell
higher
affin
receptor
salzmann
bachmann
sykulev
et
al
mean
cell
improv
antigen
respons
twofold
fourfold
viral
infect
prior
studi
compar
cell
peak
immun
respons
cell
memori
phase
time
point
select
cell
suffici
numer
readili
detect
thencurr
method
howev
technolog
advanc
allow
us
investig
antigenrespons
virusspecif
cell
much
earlier
time
postinfect
cell
number
found
approxim
day
postinfect
quantiti
peptid
antigen
need
trigger
cytokin
product
virusspecif
cell
diminish
remain
stabl
thereaft
essenti
lifetim
anim
optim
abil
trigger
low
level
antigen
cell
ensur
recogn
cell
earli
minuteshour
becom
infect
thu
maxim
chanc
cell
effector
function
eg
cytokin
product
cytolyt
activ
exert
viru
opportun
complet
cycl
replic
matur
egress
occur
without
demonstr
select
cell
bear
highaffin
tcr
propos
optim
mediat
hardwir
signal
transduct
apparatu
suggest
confirm
anoth
studi
light
propos
addit
explan
vivo
affin
ceil
tcr
cell
serial
killer
biolog
function
reli
abl
rapidli
disengag
one
target
cell
move
anoth
antivir
activ
might
fatal
compromis
cell
irrevoc
link
target
cell
highaffin
tcr
explan
consist
eleg
studi
show
optim
dwell
time
interact
epitopeclass
complex
tcr
cell
interact
weak
strong
cell
prolifer
cell
bear
tcr
right
rapidli
expand
thu
includ
antivir
immun
respons
kalergi
et
al
explain
cell
increas
antigenrespons
vivo
becom
abl
respond
lower
level
antigen
recent
studi
suggest
peptidemhc
complex
suffici
stimul
coordin
signal
via
tcr
irvin
et
al
case
antigensensit
activ
cell
approach
lowest
possibl
limit
antigen
concentr
cell
surfac
els
might
cell
improv
effector
respons
reason
might
increas
speed
begin
cytokin
product
trigger
antigen
contact
determin
quickli
epitopespecif
popul
cell
could
initi
ifnsynthesi
respons
antigen
contact
onrat
proport
cell
synthes
ifnwa
evalu
hr
peptid
exposur
respons
hr
defin
prior
respons
plot
fraction
maximum
respons
time
taken
cell
respond
antigen
halfmaxim
onrat
identifi
popul
repres
result
shown
fig
cell
harvest
day
postinfect
approxim
h
decreas
markedli
day
day
day
postinfect
cell
popul
becom
maxim
respons
antigen
contact
h
rapid
respons
retain
longterm
immun
anim
day
reinfect
longterm
immun
mice
appreci
acceler
respons
day
indic
approxim
h
may
repres
fastest
possibl
respons
cell
popul
data
shown
import
ask
whether
acceler
responsefrom
like
biolog
signific
although
improv
may
first
blush
appear
modest
one
must
rememb
virus
singl
round
propag
infect
replic
releas
infecti
progeni
take
place
short
time
period
usual
h
consequ
even
small
increas
rapid
trigger
cell
express
antivir
function
might
substanti
decreas
abil
viru
complet
replic
cycl
infect
cell
onset
ifnsynthesi
becom
rapid
cell
matur
mice
infect
lcmv
matur
effector
function
follow
determin
cell
harvest
cours
infect
valu
one
epitopespecif
cell
popul
day
primari
viru
infect
shown
droparrow
shown
cytokin
product
cell
tightli
regul
ifnand
tumor
necrosi
factor
tnf
produc
cell
contact
cognat
antigen
slifka
et
al
howev
shown
fig
pattern
cytokin
produc
virusspecif
cell
chang
immun
respons
infect
proce
slifka
whitton
cell
harvest
lcmvinfect
balbc
mice
expans
phase
primari
respons
day
postinfect
mani
virus
expos
antigen
vitro
two
broad
popul
distinguish
one
produc
ifn
produc
ifnand
tnf
respons
contract
day
ratio
two
popul
chang
doubleposit
cell
outnumb
singleposit
cell
approxim
process
continu
memori
phase
day
time
almost
cell
respond
antigen
contact
immedi
produc
ifnand
tnf
matur
shift
cytokin
profil
also
observ
follow
lcmv
infect
mice
recombin
vaccinia
viru
infect
shown
similar
chang
phenotyp
occur
respons
secondari
infect
shown
cell
initi
doubleposit
ie
memori
phenotyp
soon
infect
singleposit
cell
appear
infect
clear
popul
revert
doubleposit
memori
phenotyp
observ
confirm
influenza
model
murin
gamma
herpesviru
model
liu
et
al
physiolog
signific
chang
determin
cell
respons
detect
mani
infect
human
mice
mani
situat
indispens
effect
immun
cell
display
pleiotrop
function
immun
respons
microbi
infect
center
event
orchestr
action
movement
subset
cell
includ
b
cell
cell
dendrit
cell
macrophag
case
also
may
combat
infect
directli
describ
next
fig
cytokin
produc
upon
antigen
contact
chang
cell
respons
matur
mice
infect
lcmv
indic
time
point
postinfect
sacrif
spleen
harvest
determin
pattern
cytokin
product
cell
cours
primari
viru
infect
splenic
cell
respons
determin
use
intracellular
cytokin
stain
procedur
acquir
data
analyz
use
cellquest
softwar
cell
shown
cell
indic
xand
yax
repres
tnf
ifn
respect
technolog
develop
permit
accur
quantit
virusspecif
cell
respons
without
vitro
expans
use
flowcytometrybas
assay
includ
intracellular
stain
ifnor
tnf
respons
follow
number
infect
like
respons
respons
show
three
phase
expans
contract
longterm
memori
differ
two
cell
type
howev
report
three
phase
like
respons
transient
exposur
antigen
induc
program
prolifer
lee
et
al
great
major
cell
activ
infect
antigenspecif
ie
cell
driven
nonspecif
bystand
activ
homann
et
al
whitmir
et
al
howev
cell
respons
typic
much
lower
magnitud
concurr
cell
respons
maini
et
al
maini
et
al
whitmir
et
al
whitmir
et
al
differ
correl
lower
prolifer
rate
reveal
brdu
incorpor
cfse
label
estim
week
follow
lcmv
infect
virusspecif
cell
undergo
nine
cell
divis
homann
et
al
surviv
prolifer
cell
improv
prolong
antigen
stimul
lee
et
al
expans
phase
also
regul
sever
costimulatori
interact
includ
whitmir
et
al
suresh
et
al
kopf
et
al
ico
kopf
et
al
although
interact
requir
thelpindepend
cell
respons
cell
may
regul
tightli
cell
via
express
molecul
inhibit
prolifer
bird
et
al
doyl
et
al
also
evid
intrins
differ
prolif
potenti
cell
cell
fould
et
al
perhap
cell
differenti
requir
prolongedrep
antigen
contact
wherea
cell
commit
full
differenti
brief
stimul
kaech
ahm
van
stipdonk
et
al
contract
cell
respons
quantit
similar
cell
cell
die
howev
contrast
abrupt
contract
cell
usual
complet
within
week
peak
respons
cell
contract
linger
cours
sever
week
homann
et
al
kamperschro
quinn
treatment
increas
prolifer
surviv
cell
blattman
et
al
suggest
cytokin
withdraw
may
play
import
part
cell
contract
number
report
shown
cell
respons
lcmv
sendai
viru
influenza
viru
mice
readili
detect
long
infect
clear
topham
doherti
topham
et
al
varga
welsh
whitmir
et
al
cell
memori
maintain
absenc
antigen
mhc
class
ii
swain
et
al
studi
suggest
memori
even
stabl
memori
chang
et
al
varga
et
al
somewhat
controversi
one
studi
report
declin
memori
cell
number
prolong
period
contrast
memori
cell
remain
stabl
mice
homann
et
al
chang
correl
level
antiapoptot
molecul
lower
memori
cell
memori
cell
despit
conflict
conclus
studi
clear
cell
memori
regul
differ
cell
memori
exampl
appear
surviv
memori
cell
depend
tan
et
al
cell
lack
common
cytokin
receptor
chain
surviv
indic
may
requir
lantz
et
al
howevera
evid
understand
process
far
completea
recent
paper
report
homeostasi
memori
cell
regul
signal
seddon
et
al
memori
cell
show
improv
respons
antigen
respond
quickli
antigen
reencount
produc
cytokin
homann
et
al
roger
et
al
part
cell
front
line
biolog
effect
exert
directli
upon
infect
cell
function
cell
dispar
usual
serv
assist
otherwis
regul
respons
b
cell
cell
main
function
provid
help
lymphocyt
cell
often
term
helper
h
cell
least
two
differ
subset
h
defin
accord
pattern
cytokin
product
h
cell
produc
ifn
lymphotoxin
tnf
wherea
h
cell
produc
h
cell
associ
induct
subclass
igg
antibodi
h
cell
direct
product
h
h
cell
induc
follow
mani
viral
infect
includ
cmv
kalla
et
al
tsai
et
al
hiv
imami
et
al
ebv
steigerwaldmullen
et
al
wilson
et
al
rsv
bendelja
et
al
tripp
et
al
hbv
diepold
et
al
hcv
godkin
et
al
rosen
et
al
tsai
et
al
measl
viru
ovsyannikova
et
al
ward
griffin
human
cell
also
induc
follow
lcmv
su
et
al
whitmir
et
al
influenza
graham
et
al
sendai
coxsackieviru
huber
pfaeffl
rsv
srikiatkhachorn
et
al
tripp
et
al
other
mice
ratio
h
h
cell
induc
infect
vari
markedli
depend
infecti
agent
host
genet
background
cell
type
specif
epitop
whitmir
et
al
evid
argu
antigen
dose
alon
dictat
type
h
cell
induc
correl
h
h
ratio
induc
viru
infect
clinic
outcom
imami
et
al
tsai
et
al
wang
et
al
although
controversi
issu
bergamini
et
al
exampl
clearanc
acut
hcv
infect
associ
strong
h
cell
respons
wherea
individu
develop
chronic
hcv
infect
predominantli
h
respons
tsai
et
al
virus
measl
viru
hcmv
mcmv
found
induc
gener
h
h
shift
caus
immun
suppress
studi
chronic
lcmv
infect
indic
primari
h
cell
respons
reduc
magnitud
ciurea
et
al
compar
acut
lcmv
infect
cell
affect
fuller
zajac
virusspecif
cell
initi
induc
disappear
time
fuller
zajac
oxeniu
et
al
contrast
mice
infect
gammaherpesviru
persist
low
level
virusspecif
cell
respons
detect
long
initi
infect
flano
et
al
term
activ
requir
fewer
h
h
cell
induc
viru
infect
absenc
intact
costimul
pathway
whitmir
et
al
howev
model
system
provid
evid
h
cell
lower
relianc
costimul
definit
h
h
subset
clearand
evid
cell
line
chromosom
restructur
suggest
irrevoc
differentiationi
possibl
vivo
infect
cell
time
make
cytokin
class
preced
human
infect
cmv
kalla
et
al
best
detect
elisa
elispot
assay
proof
mice
must
await
improv
intracellular
stain
techniqu
allow
costain
ifnand
c
antivir
function
cell
long
recogn
function
cell
abil
induc
b
cell
differenti
involv
class
switch
transit
virusspecif
memori
b
cell
antibodysecret
plasma
cell
preexist
antibodi
first
line
defens
reinfect
cell
function
crucial
protect
cell
drive
b
cell
differenti
prolifer
act
pathway
modifi
antibodi
classswitch
stimul
b
cell
ifnor
differenti
event
occur
primarili
germin
center
activ
cell
associ
antigenreact
b
cell
garsid
et
al
pape
et
al
cell
deliv
help
b
cell
antigenspecif
manner
memori
b
cell
intern
viral
antigen
via
surfacebound
antibodi
antigen
process
within
b
cell
epitop
peptid
present
cell
surfac
associ
mhc
class
ii
molecul
section
iib
cell
specif
epitop
therefor
trigger
ensur
viru
infect
virusspecif
cell
trigger
respond
signal
deliv
virusspecif
memori
b
cell
recent
studi
identifi
protein
name
sap
play
key
role
differenti
cell
wu
et
al
sapdefici
mice
mount
antigenspecif
cell
respons
infect
cell
support
develop
longliv
plasma
cell
crotti
et
al
reason
sap
cell
unabl
provid
particular
type
help
remain
unknown
cell
make
normal
amount
ifn
express
mani
virus
eg
lcmv
sendai
vaccinia
influenza
ectromelia
theiler
viru
induc
strong
primari
cell
respons
even
absenc
cell
ahm
et
al
belz
et
al
belz
et
al
buller
et
al
hou
et
al
johnson
et
al
mo
et
al
infect
often
system
may
directli
activ
innat
defens
apc
costimulatori
molecul
express
infect
apc
olson
et
al
wu
liu
infect
may
instead
express
peptid
high
avid
mhc
class
tcr
franco
et
al
heath
et
al
thu
trigger
program
cell
differenti
without
need
accessori
molecul
express
contrast
virus
replic
lower
extent
local
peripher
site
often
induc
detect
primari
cell
respons
cell
present
exampl
thelpdepend
antivir
cell
respons
mice
induc
rauscher
leukemia
viru
japanes
enceph
viru
herp
simplex
viru
mous
hepat
viru
edelmann
wilson
hom
et
al
jen
et
al
muralikrishna
et
al
stohlman
et
al
cell
provid
help
cell
least
two
way
first
describ
previous
involv
apc
licens
via
enhanc
costimulatori
signal
deliv
naiv
cell
trigger
program
prolifer
differenti
second
mean
cell
enhanc
primari
respons
secret
effect
cell
manifold
cytokin
induc
fasl
express
cell
thu
increas
cell
cytotox
potenti
esser
et
al
also
may
increas
ifnproduct
cell
cousen
et
al
thu
augment
prolifer
cell
cousen
et
al
prolong
surviv
akbar
et
al
blattman
et
al
kelli
et
al
krummel
et
al
effector
cell
pursu
virusinfect
cell
longer
period
time
exampl
coronaviru
infect
cn
high
number
cell
cell
found
brain
parenchyma
hare
et
al
cell
absent
coronavirusspecif
cell
still
migrat
site
infect
cn
much
like
undergo
apoptosi
stohlman
et
al
consist
vivo
requir
produc
final
strong
evid
suggest
memori
cell
number
influenc
blattman
et
al
howev
also
deleteri
effect
cell
includ
increas
apoptosi
activ
cell
depend
much
produc
extent
cell
stimul
van
parij
et
al
given
possibl
oppos
effect
interest
learn
cell
product
cytokin
regul
conceiv
differ
amount
cytokin
produc
differ
time
depend
effect
need
addit
possibl
effect
primari
cell
respons
cell
also
may
regul
qualiti
quantiti
cell
memori
primari
respons
lcmv
influenza
viru
rel
normal
mice
memori
respons
measur
limit
dilut
assay
secondari
infect
much
reduc
belz
et
al
von
herrath
et
al
recent
public
suggest
cell
may
deliv
signal
earli
program
naiv
cell
facilit
surviv
ensur
respond
appropri
secondari
antigen
challeng
section
cell
also
may
play
key
role
sustain
cell
persist
viru
infect
persist
infect
absenc
cell
cell
quickli
delet
render
nonrespons
battegay
et
al
hunzik
et
al
matloubian
et
al
zajac
et
al
cell
orchestr
mani
aspect
antivir
immun
respons
cell
therefor
said
mani
distinct
antivir
function
exampl
alreadi
describ
provis
help
b
cell
consid
antivir
function
absenc
antivir
antibodi
respons
compromis
viru
therebi
gain
advantag
effectswhich
result
wellestablish
helper
activ
cellshav
extens
catalogu
appear
constitut
great
major
antivir
effect
cell
howev
effect
indirect
mediat
effector
cell
eg
cell
b
cell
describ
previous
macrophag
discuss
herein
molecul
produc
cell
eg
antibodi
addit
indirect
effect
one
conceiv
least
two
way
cell
might
exert
antivir
effect
first
cell
might
act
directli
virusinfect
target
cell
express
viral
epitop
associ
mhc
class
ii
would
analog
front
line
activ
cell
second
one
could
envis
cell
might
encount
antigenexpress
uninfect
apc
trigger
produc
cytokin
directli
inhibit
replic
virus
adjac
infect
probabl
mhc
class
ii
neg
cell
herein
shall
term
bystand
antivir
effect
thu
suggest
cell
may
exert
antivir
effect
three
way
direct
manner
indirect
manner
bystand
indirect
effect
discuss
previous
evid
remain
two
mechan
possibl
direct
antivir
effect
cell
cell
may
mediat
direct
purg
mhc
class
iiexpress
cell
b
cell
infect
exampl
ebv
murin
gamma
herpesviru
macrophag
dendrit
cell
infect
sever
virus
microglia
target
sever
cn
infect
includ
theiler
viru
mous
hepat
viru
howev
restrict
anatom
distribut
mhc
class
ii
molecul
mean
cell
may
unabl
recogn
act
directli
upon
great
major
cell
becom
infect
follow
viru
challeng
present
obviou
obstacl
concept
cell
commonli
exert
direct
antivir
effect
section
iii
nevertheless
clear
sever
cell
type
eg
epitheli
cell
upregul
mhc
class
ii
express
viral
infect
render
potenti
recogniz
tcell
furthermor
exist
cytolyt
tcell
doubt
one
might
infer
cellwhos
cytolyt
effect
reli
direct
contact
antigenexpress
target
cellar
unlik
exist
without
good
reason
cytolyt
cell
first
identifi
vivo
distinct
cell
line
clone
lcmvinfect
mice
muller
et
al
subsequ
care
analys
suggest
virusspecif
cell
could
exert
profound
effect
absenc
cell
quinn
et
al
inde
mice
clear
lcmv
infect
despit
lack
cell
muller
et
al
suggest
prove
cell
might
direct
antivir
effect
interpret
strengthen
observ
zajac
et
al
cytotox
effect
cell
fasmedi
ii
vivo
effect
fasdepend
fasdepend
strongli
suggest
effect
requir
direct
cell
cell
interact
fasl
cell
fasexpress
target
cell
howev
model
mice
fraught
difficulti
review
freling
serodi
direct
cytolyt
effect
cell
infect
cell
vivo
remain
demonstr
cytolyt
cell
also
identifi
follow
epsteinbarr
viru
infect
khanolkar
et
al
perforin
cell
report
hiv
infect
individu
appay
et
al
mere
exist
cell
howev
consid
proof
direct
inde
antivir
effect
perhap
best
evid
direct
cellmedi
control
infect
murin
gammaherpesviru
model
appear
like
although
certain
cell
exert
effect
via
ifnproduct
directli
virusinfect
mhc
class
iiposit
target
cell
christensen
et
al
circumstanti
evid
consist
idea
cell
may
exert
direct
effector
function
cell
gener
thought
function
spleen
lymph
node
increas
evid
memori
cell
resid
peripher
nonlymphoid
site
hogan
et
al
marzo
et
al
mcsorley
et
al
reinhardt
et
al
cell
show
highli
activ
phenotyp
elev
level
decreas
level
make
distinct
splenic
memori
cell
hogan
et
al
cell
peripheri
tend
make
ifn
arguabley
consist
direct
effector
function
resid
preferenti
lymphoid
organ
make
consist
immunoregulatori
activ
howev
argument
much
conjectur
except
exist
note
cell
coronavirusinfect
brain
produc
surviv
factorsposs
rescu
cell
b
possibl
bystand
antivir
effect
cell
mani
situat
exist
transfer
virusspecif
cell
profound
effect
outcom
viru
infect
andor
diseas
exampl
transfer
poliovirusspecif
cell
humanpoliovirusreceptor
transgen
mice
protect
recipi
lethal
polioviru
infect
mahon
et
al
infect
neuron
requir
lethal
outcom
cell
usual
express
mhc
class
ii
molecul
therefor
effect
unlik
direct
similarli
transfer
hbvspecif
effector
cell
reduc
viral
load
mice
transgen
hbv
franco
et
al
cell
mediat
protect
sendai
infect
independ
antibodi
cell
zhong
et
al
evalu
possibl
bystand
effect
mediat
cell
chimer
mice
produc
express
mhc
class
ii
molecul
cell
other
use
approach
shown
influenza
virusspecif
cell
clear
infect
mhc
class
iineg
cell
consist
bystand
effect
howev
indirect
antibodymedi
effect
exclud
topham
et
al
cytokin
profil
cell
chang
time
peak
respons
lcmv
cell
respons
h
phenotyp
mixtur
virusspecif
cell
make
ifn
ifnand
ifnand
tnf
three
cytokin
major
cell
make
ifnin
respons
antigen
contact
although
approxim
also
make
harrington
et
al
varga
welsh
synthes
tnf
harrington
et
al
homann
et
al
varga
welsh
contrast
memori
phase
singleposit
cell
identifi
essenti
cell
doubleposit
tnf
harrington
et
al
homann
et
al
pattern
reminisc
chang
report
cell
slifka
whitton
fig
signific
chang
unclear
could
cytokin
doubleposit
cell
differenti
singleposit
cell
singleposit
cell
distinct
lineag
terminallydifferenti
shortliv
effector
cell
like
cell
cell
categor
central
memori
cell
defin
hi
effector
memori
cell
lo
express
affect
local
cell
central
memori
cell
preferenti
local
secondari
lymphoid
organ
effector
memori
cell
travel
peripher
site
howev
cell
clear
relationship
cell
effector
function
express
marker
protein
immun
respons
invari
success
control
infect
infect
remain
major
increas
caus
human
morbid
mortal
easi
forgiv
occasion
failur
part
immun
system
especi
one
consid
innumer
strategi
develop
microb
evad
unwelcom
attent
howev
import
realiz
success
immun
respons
deliv
cost
erad
infect
immun
system
also
damag
host
phenomenon
term
immunopatholog
extrem
common
featur
viru
infect
mani
symptom
common
viral
infectionsfor
exampl
chill
muscl
ach
fever
influenza
well
characterist
rash
measlesar
caus
directli
viru
instead
result
immun
respons
viru
detail
review
topic
would
far
exceed
scope
chapter
suffic
say
natur
cell
responsewhich
often
involv
lysi
infect
cell
releas
highli
toxic
cytokinesmean
immunopatholog
almost
inevit
consequ
viral
infect
argu
need
minim
immunopatholog
provid
strong
select
pressur
ensur
effector
function
cell
held
extraordinarili
tight
rein
slifka
whitton
slifka
et
al
moreov
antibodi
consid
innoc
parti
antibodyantigen
complex
may
deposit
variou
anatom
interfac
eg
basement
membran
kidney
lead
complement
activ
sever
inflammatori
damag
one
key
question
approach
infrequ
ask
uncoupl
harm
benefici
effect
immun
respons
coxsacki
viru
infect
human
mice
often
result
sever
myocard
survivor
extens
myocardi
scar
often
caus
dilat
cardiomyopathi
treatabl
transplant
approv
treatment
coxsacki
viru
myocard
use
mous
model
found
myocard
subsequ
scar
much
reduc
perforindefici
mice
anim
clear
viru
infect
kinet
indistinguish
observ
normal
mice
gebhard
et
al
thu
suggest
develop
reagent
capabl
specif
block
perforin
activ
might
permit
treatment
coxsacki
viru
myocard
without
compromis
host
abil
recov
infect
evolutionari
pressur
impos
unremit
onslaught
infecti
agent
shape
mammalian
immun
system
exist
stand
proof
potenc
antimicrobi
immun
respons
cooper
natur
antibodi
cell
arm
adapt
immun
system
long
recogn
understand
immun
respons
infect
remain
far
complet
recent
studi
begun
reveal
previous
unappreci
subtleti
cell
respons
tailor
effect
detect
viral
challeng
provid
rapid
effect
repli
safer
effect
vaccin
design
harm
effect
immun
respons
diminish
retain
benefici
compon
must
rest
laurel
mani
import
question
remain
answer
